A*STAR Bioprocessing Technology Institute (A*STAR BTI)

Identification of a signaling pathway could aid development of stem cell-based therapies for Parkinson’s disease

Fibroblast growth factor-2 keeps stems cells in their undifferentiated state by activating Wnt signaling

Tyrosine phosphorylation profiles illuminate the molecular basis of self-renewal in human embryonic stem cells

Chinese hamster ovary and baby hamster kidney cell lines are the best choices for producing therapeutic glycoprotein that stays in the bloodstream longer

A new bioprocessing system enables large-scale production of heart muscle cells from stem cells

Efficient production of glycoprotein drugs to treat anemia and other disorders comes a step closer via genetic engineering

An evaluation study shows that more efficient cell-sorting methods are needed to make stem cell-derived tissues sufficiently safe for transplantation

An antibody that selectively kills off undifferentiated stem cells may improve their clinical usefulness

Embryonic stem cells keep their developmental options open with help from two recently identified genes